Catherine Q. Sun

Tube Versus Trabeculectomy IRISRegistry 1-Year Composite Outcome Analysis with Comparisons to the Randomized Controlled Trial.

Our results were different from those in the TVT RCT. Possible reasons include non-Baerveldt tubes, greater severity among tube eyes, and practice patterns that reflect real-world data, which are different than those in RCTs.

The Tube Versus Trabeculectomy IRIS® Registry Study: Cohort Selection and Follow-up and Comparisons to the Randomized Controlled Trial.

The TVT IRIS Registry cohort had several significant treatment group differences at baseline, whereas there had been none in the TVT RCT cohort.

Improving Outcomes in Neovascular Glaucoma.

Tube Versus Trabeculectomy IRIS Registry Study: 1-Year Secondary Treatment Outcomes.

The TVTtube and trabeculectomy groups had comparable 1-year IOP reduction, although trabeculectomy eyes used fewer glaucoma medications.

Gap Analysis of Glaucoma Examination Concept Representations within Standard Systemized Nomenclature of Medicine - Clinical Terms.

There are existing gaps in the standardized representation of findings related to tonometry and gonioscopy within SNOMED-CT.

Open Angle Glaucoma Treatment Preferences of Glaucoma Specialists in the United States.

The majority of US glaucoma specialists report a preference for SLT over medication for open angle glaucoma treatment, demonstrating that acceptance of SLT has increased over the past several years, especially for treatment-naïve patients.

Registry-based randomised controlled trials in glaucoma: the time is right?